Biopharmaceutical organizations are increasing their R&D spend, but with growing challenges from competitors, supply chain costs and other geopolitical factors, they are not able to maintain R&D productivity. Digitally transform your operations with IDBS - enabling you to make the agile, data driven decisions you can trust, to overcome these obstacles and get your therapeutic to market faster. Discuss more with our experts at Interphex Korea booth E08. Learn more: https://ow.ly/YGLn50Syasn #digitaltransformation #biopharma
IDBS’ Post
More Relevant Posts
-
New challenges are testing the resilience of the supply chain in the pharma sector. Recently, there were GLP-1 supply chain shortages and, realistically, intermittent weaknesses are expected to continue along this year. In addition, the increasing interest in mRNA-based applications, being highly sensitive, requires important technical considerations and issues to solve throughout the supply chain, as cold storage stresses the overall system, potentially compromising some of its components. Stevanato Group works daily to address these challenges by focusing on a double effort. From one side, we invest in R&D, which is also a key component of our vision enabling us to be an holistic strategic partner for biopharmaceutical companies, on the other we focus on digitalization, aiming to leverage its full potential for inspection and assembly solutions to achieve real-time improvements in productivity and quality, while reducing risk. #StevanatoGroup #supplychain #pharma #innovation #digitaltransformation
To view or add a comment, sign in
-
Today, we turn our attention to the #Pharmaceutical #Manufacturing industry sector. They have just as many supply chain challenges as any other industry coupled with even tighter regulation and the need to facilitate effective data communications. "For instance, a better data management system can help pharma manufacturers better communicate sensitive data (supply chain forecasting), improve compliance, enable knowledge sharing across the organization, and create a single source of truth for data-driven organizations."- Pharma Manufacturing Securely, moving beyond spread sheets holds the key... https://lnkd.in/gBRstEkP
To view or add a comment, sign in
-
Outsourced commercialization solutions help pharmaceutical manufacturers more completely realize a drug's commercial potential over its full product life cycle. It’s a dynamic segment continually creating new opportunities for M&A investors. In this article, we discuss the shifting tech and data needs in commercialization solutions and how our recent client, IntegriChain, exemplifies the opportunity. https://lnkd.in/e-aGUeEP Dr Julian Feneley, Paul Hepper, Dan Linsalata, Andrey Dvorkin
Pharma Commercialization Solutions: Shifting Tech & Data Needs
harriswilliams.com
To view or add a comment, sign in
-
Twelve Days of Fulfillment 🎄 Day Seven: A Success-Stuffed Stocking: A Fulfillment Case Study 💡 When selecting a fulfillment partner, you must do your due diligence before signing any contracts. This means taking the time to speak with current clients, reviewing case studies and gaining a clear understanding of the company's culture. A thorough evaluation ensures you’re choosing a partner that aligns with your goals and values. To provide further insight, we’ve highlighted several fulfillment case studies that demonstrate our expertise and the impactful results we've delivered. 🧬 Biopharmaceutical: https://lnkd.in/e7R6G2xX 🍾 Global Spirits and Beverages: https://lnkd.in/exU5zqWG ⚓ Leisure Entertainment: https://lnkd.in/eMT8-F-j Please reach out to learn more: Susan.Coyne@hartehanks.com #fulfillmentcasestudies #fulfillment #digitalprint #Globalspirits #Biopharmaceuticals #LeisureEntertainment Harte Hanks
To view or add a comment, sign in
-
A robust competitive strategy empowers pharmaceutical teams to anticipate market shifts, identify emerging threats, and capitalize on new opportunities. When done well, it provides a critical edge – enabling well-informed decisions that drive and sustain brand success. Read our latest article, introducing our comprehensive and proven 6D framework to enhance the crafting of your competitive strategy: https://buff.ly/4gfAy3Y #brandplanning #competitivestrategy #competition #competitiveintelligence Alexander Fink, Emma Gehrke
To view or add a comment, sign in
-
If the ambition is to “dominate” the $150 billion market in weight loss, the pharmaceutical industry is either asking the wrong questions, or the questions are based on the wrong camera angle. Don't let all the AI-enabled slop distract. When it comes to sparking big growth curves, think 'market Interoperability' first, data interoperability second. Published on #FreshPaint
To view or add a comment, sign in
-
From Ohio to North Carolina, Big Pharma is doubling down on domestic production. Pharmaceutical giants are reshaping the industry with billion-dollar investments in U.S.-based manufacturing facilities. These moves are more than just economic milestones—they're a response to global disruptions, a commitment to quality control, and a step toward more resilient supply chains. With local facilities, companies gain end-to-end oversight, reduced reliance on foreign production, and streamlined compliance with FDA standards. These changes promise fewer delays, stronger supply chain security, and better outcomes for patients. Read the full article for insights here: https://lnkd.in/grEZKbNH #Pharmaceuticals #SupplyChainResilience #USManufacturing
To view or add a comment, sign in
-
Sign up now: https://bit.ly/3TTazFW Get critical business insights from an IDC guest speaker on how to leverage the right multi-enterprise supply chain commerce network to gain real-time visibility, collaboration, and info exchange and boost performance in today's complex supply chain. Sign up today! #Supplychain #Pharmaceutical #LifeSciences #Pharma #manufacturing
To view or add a comment, sign in
-
#event Yesterday, we held a live seminar at our Tokyo headquarters, with around 100 guests, including representatives from 54 pharmaceutical companies, wholesalers, and transportation partners. This was the fourth seminar held this year, and the culminating theme for this session was "The Physical Internet of Logistics." At the seminar, we invited guests from the Ministry of Economy, Trade, and Industry, as well as the Boston Consulting Group, who delivered presentations reflecting on the 2024 issues and discussing the concept of the Physical Internet in logistics. Finally, our CEO presented a proposal for industry-wide standardization, aimed at driving further progress. Our objective is to advance standardization within the pharmaceutical logistics industry, enhance data connectivity and traceability of goods, and ultimately achieve industry-wide optimization. #OtsukaWarehouse #pharmaceutical #logistics #2024
To view or add a comment, sign in
-
Sign up now: https://bit.ly/3TTazFW Get critical business insights from an IDC guest speaker on how to leverage the right multi-enterprise supply chain commerce network to gain real-time visibility, collaboration, and info exchange and boost performance in today's complex supply chain. Sign up today! #Supplychain #Pharmaceutical #LifeSciences #Pharma #manufacturing
To view or add a comment, sign in
13,073 followers